Cargando…

Current status of PET imaging in neuro-oncology

Over the past decades, a variety of PET tracers have been used for the evaluation of patients with brain tumors. For clinical routine, the most important clinical indications for PET imaging in patients with brain tumors are the identification of neoplastic tissue including the delineation of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galldiks, Norbert, Lohmann, Philipp, Albert, Nathalie L, Tonn, Jörg C, Langen, Karl-Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324052/ https://www.ncbi.nlm.nih.gov/pubmed/32642650 http://dx.doi.org/10.1093/noajnl/vdz010

Ejemplares similares

Use of PET Imaging in Neuro-Oncological Surgery
por: Holzgreve, Adrien, et al.
Publicado: (2021)

Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
por: Werner, Jan-Michael, et al.
Publicado: (2020)

Advances in PET imaging for meningioma patients
por: Galldiks, Norbert, et al.
Publicado: (2023)

Boosting the acceptance of (18)F-FET PET for image-guided treatment planning with a multi-centric prospective trial
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology
por: Galldiks, Norbert, et al.
Publicado: (2021)

Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives
por: Langen, Karl-Josef, et al.
Publicado: (2023)

Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
por: Galldiks, Norbert, et al.
Publicado: (2016)

Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
por: Wollring, Michael M., et al.
Publicado: (2022)

Amino acid PET and MR perfusion imaging in brain tumours
por: Filss, Christian P., et al.
Publicado: (2017)

Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients
por: Lohmann, Philipp, et al.
Publicado: (2019)

Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
por: Galldiks, Norbert, et al.
Publicado: (2012)

Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours
por: Lohmann, Philipp, et al.
Publicado: (2014)

Evolution and implementation of radiographic response criteria in neuro-oncology
por: Ramakrishnan, Divya, et al.
Publicado: (2023)

The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
por: Galldiks, Norbert, et al.
Publicado: (2016)

PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)

O-(2-[(18)F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres
por: Filss, Christian P., et al.
Publicado: (2017)

Imaging findings following regorafenib in malignant gliomas: FET PET adds valuable information to anatomical MRI
por: Galldiks, Norbert, et al.
Publicado: (2019)

Evaluation of FET PET Radiomics Feature Repeatability in Glioma Patients
por: Gutsche, Robin, et al.
Publicado: (2021)

Feature-based PET/MRI radiomics in patients with brain tumors
por: Lohmann, Philipp, et al.
Publicado: (2021)

Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
por: Chiu, Fang-Ying, et al.
Publicado: (2023)

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0
por: Law, Ian, et al.
Publicado: (2018)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

Combined (18)F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes
por: D’Amore, Francesco, et al.
Publicado: (2021)

Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
por: Bauer, Elena Katharina, et al.
Publicado: (2021)

Imaging in neuro-oncology
por: Nandu, Hari, et al.
Publicado: (2018)

MLTI-17. DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS USING COMBINED FET PET/MRI RADIOMICS
por: Lohmann, Philipp, et al.
Publicado: (2019)

Use of advanced neuroimaging and artificial intelligence in meningiomas
por: Galldiks, Norbert, et al.
Publicado: (2022)

PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
por: Verger, Antoine, et al.
Publicado: (2022)

What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review
por: Zhang-Yin, Jules Tianyu, et al.
Publicado: (2022)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
por: Lin, Mai, et al.
Publicado: (2022)

The Emerging Role of Amino Acid PET in Neuro-Oncology
por: Najjar, Amer M., et al.
Publicado: (2018)

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
por: Lohmann, Philipp, et al.
Publicado: (2018)

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
por: Brahm, Cyrillo G., et al.
Publicado: (2020)

PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology
por: Wiggins, Richard H., et al.
Publicado: (2022)

(18)F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection
por: Ort, Jonas, et al.
Publicado: (2021)

Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
por: Kasten, Benjamin B., et al.
Publicado: (2019)

32. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING AMINO ACID PET IN PATIENTS WITH BRAIN METASTASES
por: Galldiks, Norbert, et al.
Publicado: (2020)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

PET/CT in Oncology: Current Status and Perspectives
por: Czernin, Johannes, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7l7ed0k4d1h8h6dnpprkn5k3r7